Artículos por temáticas

At-Home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact

Boess FG, Scelsi MA, Grimmer T, Perry RJ, Tonietto M, Klein G, Hofmann C, Salami M, Wojtowicz J, Lansdall CJ, Lane C, Kerchner GA, Smith J, Doody RS.

J Prev Alzheimers Dis. 2024;11(3):537-548. doi: 10.14283/jpad.2024.60.

Musical Mnemonics in Cognitively Unimpaired Individuals and Individuals with Alzheimer's Dementia: A Systematic Review

Derks-Dijkman MW, Schaefer RS, Kessels RPC.

Neuropsychol Rev. 2024 Jun;34(2):455-477. doi: 10.1007/s11065-023-09585-4. Epub 2023 Apr 14.

Unveiling the theranostic potential of SPIONs in Alzheimer's disease management

Aminyavari S, Afshari AR, Ahmadi SS, Kesharwani P, Sanati M, Sahebkar A.

J Psychiatr Res. 2024 Nov;179:244-256. doi: 10.1016/j.jpsychires.2024.09.022. Epub 2024 Sep 20.

A closer look at amyloid ligands, and what they tell us about protein aggregates

Chisholm TS, Hunter CA.

Chem Soc Rev. 2024 Feb 5;53(3):1354-1374. doi: 10.1039/d3cs00518f.

Impact of genetic predisposition to late-onset neurodegenerative diseases on early life outcomes and brain structure

Ogonowski NS, García-Marín LM, Fernando AS, Flores-Ocampo V, Rentería ME.

Transl Psychiatry. 2024 Apr 11;14(1):185. doi: 10.1038/s41398-024-02898-9.

Centiloid recommendations for clinical context-of-use from the AMYPAD consortium

Collij LE, Bollack A, La Joie R, Shekari M, Bullich S, Roé-Vellvé N, Koglin N, Jovalekic A, Garciá DV, Drzezga A, Garibotto V, Stephens AW, Battle M, Buckley C, Barkhof F, Farrar G, Gispert JD; AMYPAD

Alzheimers Dement. 2024 Dec;20(12):9037-9048. doi: 10.1002/alz.14336. Epub 2024 Nov 20.

The impact of empowerment theory-based health education on Alzheimer's disease informal caregivers: a randomized controlled trial

Liu X, Wang S, Wei L, Liu Y, Bian J, Wang S, Du X.

Front Public Health. 2024 Aug 27;12:1393823. doi: 10.3389/fpubh.2024.1393823. eCollection 2024.

[On the road to biological blood diagnosis of Alzheimer's disease?]

Delaby C, Lehmann S.

Med Sci (Paris). 2024 Apr;40(4):351-360. doi: 10.1051/medsci/2024037. Epub 2024 Apr 23.

Insights into the Role of microRNAs as Clinical Tools for Diagnosis, Prognosis, and as Therapeutic Targets in Alzheimer's Disease

Puranik N, Song M.

Int J Mol Sci. 2024 Sep 14;25(18):9936. doi: 10.3390/ijms25189936.

Interventions to Foster Resilience in Family Caregivers of People with Alzheimer's Disease: A Scoping Review

Santonja-Ayuso L, Corchón-Arreche S, Portillo MC.

Int J Environ Res Public Health. 2024 Apr 16;21(4):485. doi: 10.3390/ijerph21040485.

Neural correlates of impaired cognitive processes underlying self-unawareness in Alzheimer's disease

Salmon E, Meyer F, Genon S, Collette F, Bastin C.

Cortex. 2024 Feb;171:1-12. doi: 10.1016/j.cortex.2023.10.009. Epub 2023 Nov 1.

Effectiveness of neuro-feedback on Alzheimer's rehabilitation: a bibliometric analysis

Verma S, Kurdekar A.

Neurodegener Dis Manag. 2024;14(6):257-266. doi: 10.1080/17582024.2024.2435250. Epub 2024 Dec 4.

Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease

Shirzadi Z, Schultz AP, Properzi M, Yaari R, Yau WW, Brickman AM, Rafii MS, Donohue MC, Ernstrom K, Wang S, Jack CR Jr, Greenberg SM, Raman R, Aisen P, Sperling RA, Chhatwal JP.

J Prev Alzheimers Dis. 2024;11(4):869-873. doi: 10.14283/jpad.2024.139.

Clinical and cortical trajectories in non-fluent primary progressive aphasia and Alzheimer's disease: A role for emotion processing

Landin-Romero R, Kumfor F, Ys Lee A, Leyton C, Piguet O.

Brain Res. 2024 Apr 15;1829:148777. doi: 10.1016/j.brainres.2024.148777. Epub 2024 Jan 28.

Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review

Cabrera-León Y, Báez PG, Fernández-López P, Suárez-Araujo CP.

J Alzheimers Dis. 2024;98(3):793-823. doi: 10.3233/JAD-231271.